Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Functional Polymorphisms in DNA Repair Genes Are Associated with Sporadic Colorectal Cancer Susceptibility and Clinical Outcome

K. Jiraskova, DJ. Hughes, S. Brezina, T. Gumpenberger, V. Veskrnova, T. Buchler, M. Schneiderova, M. Levy, V. Liska, S. Vodenkova, C. Di Gaetano, A. Naccarati, B. Pardini, V. Vymetalkova, A. Gsur, P. Vodicka,

. 2018 ; 20 (1) : . [pub] 20181227

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19027953

Grantová podpora
GAUK112515 the Grant Agency of Charles University
HRA_PHS/2015/1142 the Health Research Board of Ireland
UNCE/MED/006 the Centrum of clinical and experimental liver surgery
LO1503 Ministry of Education Youth and Sports of the Czech Republic, the National Sustainability Program I
GACR 17-16857S Grantová Agentura České Republiky
Post-doctoral fellowship Year 2014-2017 the Fondazione Umberto Veronesi
AZV MZ 15-26535A the Internal Grant Agency of the Ministry of Health of the Czech Republic
AZV 17-30920A the Internal Grant Agency of the Ministry of Health of the Czech Republic
829675 the FFG BRIDGE
the Herzfelder´sche Familienstiftung the Herzfelder´sche Familienstiftung
GACR 15-14789S Grantová Agentura České Republiky
NV17-30920A MZ0 CEP - Centrální evidence projektů

DNA repair processes are involved in both the onset and treatment efficacy of colorectal cancer (CRC). A change of a single nucleotide causing an amino acid substitution in the corresponding protein may alter the efficiency of DNA repair, thus modifying the CRC susceptibility and clinical outcome. We performed a candidate gene approach in order to analyze the association of non-synonymous single nucleotide polymorphisms (nsSNPs) in the genes covering the main DNA repair pathways with CRC risk and clinical outcome modifications. Our candidate polymorphisms were selected according to the foremost genomic and functional prediction databases. Sixteen nsSNPs in 12 DNA repair genes were evaluated in cohorts from the Czech Republic and Austria. Apart from the tumor-node-metastasis (TNM) stage, which occurred as the main prognostic factor in all of the performed analyses, we observed several significant associations of different nsSNPs with survival and clinical outcomes in both cohorts. However, only some of the genes (REV3L, POLQ, and NEIL3) were prominently defined as prediction factors in the classification and regression tree analysis; therefore, the study suggests their association for patient survival. In summary, we provide observational and bioinformatics evidence that even subtle alterations in specific proteins of the DNA repair pathways may contribute to CRC susceptibility and clinical outcome.

Biomedical Centre Faculty of Medicine in Pilsen Charles University Prague 323 00 Pilsen Czech Republic Department of Surgery Medical School in Pilsen Charles University Alej svobody 80 304 600 Pilsen Czech Republic

Cancer Biology and Therapeutics Group UCD Conway Institute University College Dublin Dublin 4 Ireland

Department of Molecular Biology of Cancer Institute of Experimental Medicine of the Czech Academy of Sciences Videnska 1083 142 00 Prague Czech Republic Molecular and Genetic Epidemiology

Department of Oncology 1st Faculty of Medicine Charles University and Thomayer Hospital Videnska 800 140 59 Prague Czech Republic

Department of Surgery 1st Faculty of Medicine Charles University and Thomayer Hospital Thomayerova 815 5 140 00 Prague Czech Republic

Department of Surgery General University Hospital Prague U Nemocnice 499 2 128 08 Prague Czech Republic

Genomic Variation in Human Populations and Complex Diseases IIGM Italian Institute for Genomic Medicine Via Nizza 52 10126 Turin Italy

Genomic Variation in Human Populations and Complex Diseases IIGM Italian Institute for Genomic Medicine Via Nizza 52 10126 Turin Italy Department of Medical Sciences University of Turin Corso Dogliotti 14 10126 Turin Italy

Institute of Biology and Medical Genetics 1st Faculty of Medicine Charles University Albertov 4 128 00 Prague Czech Republic Department of Molecular Biology of Cancer Institute of Experimental Medicine of the Czech Academy of Sciences Videnska 1083 142 00 Prague Czech Republic

Institute of Biology and Medical Genetics 1st Faculty of Medicine Charles University Albertov 4 128 00 Prague Czech Republic Department of Molecular Biology of Cancer Institute of Experimental Medicine of the Czech Academy of Sciences Videnska 1083 142 00 Prague Czech Republic Biomedical Centre Faculty of Medicine in Pilsen Charles University Prague 323 00 Pilsen Czech Republic

Institute of Biology and Medical Genetics 1st Faculty of Medicine Charles University Albertov 4 128 00 Prague Czech Republic Department of Molecular Biology of Cancer Institute of Experimental Medicine of the Czech Academy of Sciences Videnska 1083 142 00 Prague Czech Republic Department of Medical Genetics 3rd Faculty of Medicine Charles University Ruska 2411 87 100 00 Prague Czech Republic

Institute of Cancer Research Department of Medicine 1 Medical University of Vienna Borschkegasse 8a A 1090 Vienna Austria

Molecular and Genetic Epidemiology

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19027953
003      
CZ-PrNML
005      
20190815114638.0
007      
ta
008      
190813s2018 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms20010097 $2 doi
035    __
$a (PubMed)30591675
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Jiraskova, Katerina $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Albertov 4, 128 00 Prague, Czech Republic. katerina.jiraskova@iem.cas.cz. Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 142 00 Prague, Czech Republic. katerina.jiraskova@iem.cas.cz.
245    10
$a Functional Polymorphisms in DNA Repair Genes Are Associated with Sporadic Colorectal Cancer Susceptibility and Clinical Outcome / $c K. Jiraskova, DJ. Hughes, S. Brezina, T. Gumpenberger, V. Veskrnova, T. Buchler, M. Schneiderova, M. Levy, V. Liska, S. Vodenkova, C. Di Gaetano, A. Naccarati, B. Pardini, V. Vymetalkova, A. Gsur, P. Vodicka,
520    9_
$a DNA repair processes are involved in both the onset and treatment efficacy of colorectal cancer (CRC). A change of a single nucleotide causing an amino acid substitution in the corresponding protein may alter the efficiency of DNA repair, thus modifying the CRC susceptibility and clinical outcome. We performed a candidate gene approach in order to analyze the association of non-synonymous single nucleotide polymorphisms (nsSNPs) in the genes covering the main DNA repair pathways with CRC risk and clinical outcome modifications. Our candidate polymorphisms were selected according to the foremost genomic and functional prediction databases. Sixteen nsSNPs in 12 DNA repair genes were evaluated in cohorts from the Czech Republic and Austria. Apart from the tumor-node-metastasis (TNM) stage, which occurred as the main prognostic factor in all of the performed analyses, we observed several significant associations of different nsSNPs with survival and clinical outcomes in both cohorts. However, only some of the genes (REV3L, POLQ, and NEIL3) were prominently defined as prediction factors in the classification and regression tree analysis; therefore, the study suggests their association for patient survival. In summary, we provide observational and bioinformatics evidence that even subtle alterations in specific proteins of the DNA repair pathways may contribute to CRC susceptibility and clinical outcome.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a kohortové studie $7 D015331
650    _2
$a kolorektální nádory $x genetika $x mortalita $x patologie $7 D015179
650    _2
$a oprava DNA $x genetika $7 D004260
650    _2
$a DNA vazebné proteiny $x genetika $7 D004268
650    _2
$a DNA-dependentní DNA-polymerasy $x genetika $7 D004259
650    _2
$a přežití bez známek nemoci $7 D018572
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a N-glykosylhydrolasy $x genetika $7 D009699
650    _2
$a metastázy nádorů $7 D009362
650    _2
$a odds ratio $7 D016017
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a analýza přežití $7 D016019
651    _2
$a Rakousko $7 D001317
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hughes, David J $u Cancer Biology and Therapeutics Group, UCD Conway Institute, University College Dublin, Dublin 4, Ireland. davidhughes@rcsi.ie.
700    1_
$a Brezina, Stefanie $u Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria. stefanie.brezina@meduniwien.ac.at.
700    1_
$a Gumpenberger, Tanja $u Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria. tanja.gumpenberger@meduniwien.ac.at.
700    1_
$a Veskrnova, Veronika $u Department of Oncology, First Faculty of Medicine, Charles University and Thomayer Hospital, Videnska 800, 140 59 Prague, Czech Republic. veskrnova.ver@gmail.com.
700    1_
$a Buchler, Tomas $u Department of Oncology, First Faculty of Medicine, Charles University and Thomayer Hospital, Videnska 800, 140 59 Prague, Czech Republic. buchlert@yahoo.com.
700    1_
$a Schneiderova, Michaela $u Department of Surgery, General University Hospital in Prague, U Nemocnice 499/2, 128 08 Prague, Czech Republic. schneider77@seznam.cz.
700    1_
$a Levy, Miroslav $u Department of Surgery, First Faculty of Medicine, Charles University and Thomayer Hospital, Thomayerova 815/5, 140 00 Prague, Czech Republic. miroslav.levy@lf1.cuni.cz.
700    1_
$a Liska, Vaclav $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, 323 00 Pilsen, Czech Republic. vena.liska@skaut.cz. Department of Surgery, Medical School in Pilsen, Charles University, Alej svobody 80, 304 600 Pilsen, Czech Republic. vena.liska@skaut.cz.
700    1_
$a Vodenkova, Sona $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Albertov 4, 128 00 Prague, Czech Republic. sona.vodenkova@iem.cas.cz. Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 142 00 Prague, Czech Republic. sona.vodenkova@iem.cas.cz. Department of Medical Genetics, Third Faculty of Medicine, Charles University, Ruska 2411/87, 100 00 Prague, Czech Republic. sona.vodenkova@iem.cas.cz.
700    1_
$a Di Gaetano, Cornelia $u Molecular and Genetic Epidemiology; Genomic Variation in Human Populations and Complex Diseases, IIGM Italian Institute for Genomic Medicine, Via Nizza 52, 10126 Turin, Italy. cdigaeta@unito.it. Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126 Turin, Italy. cdigaeta@unito.it.
700    1_
$a Naccarati, Alessio $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 142 00 Prague, Czech Republic. alessio.naccarati@iigm.it. Molecular and Genetic Epidemiology; Genomic Variation in Human Populations and Complex Diseases, IIGM Italian Institute for Genomic Medicine, Via Nizza 52, 10126 Turin, Italy. alessio.naccarati@iigm.it.
700    1_
$a Pardini, Barbara $u Molecular and Genetic Epidemiology; Genomic Variation in Human Populations and Complex Diseases, IIGM Italian Institute for Genomic Medicine, Via Nizza 52, 10126 Turin, Italy. barbara.pardini@iigm.it. Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126 Turin, Italy. barbara.pardini@iigm.it.
700    1_
$a Vymetalkova, Veronika $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Albertov 4, 128 00 Prague, Czech Republic. veronika.vymetalkova@iem.cas.cz. Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 142 00 Prague, Czech Republic. veronika.vymetalkova@iem.cas.cz. Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, 323 00 Pilsen, Czech Republic. veronika.vymetalkova@iem.cas.cz.
700    1_
$a Gsur, Andrea $u Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria. andrea.gsur@meduniwien.ac.at.
700    1_
$a Vodicka, Pavel $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Albertov 4, 128 00 Prague, Czech Republic. pavel.vodicka@iem.cas.cz. Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 142 00 Prague, Czech Republic. pavel.vodicka@iem.cas.cz. Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, 323 00 Pilsen, Czech Republic. pavel.vodicka@iem.cas.cz.
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 20, č. 1 (2018)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30591675 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190815114906 $b ABA008
999    __
$a ok $b bmc $g 1433102 $s 1066413
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 20 $c 1 $e 20181227 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a GAUK112515 $p the Grant Agency of Charles University
GRA    __
$a HRA_PHS/2015/1142 $p the Health Research Board of Ireland
GRA    __
$a UNCE/MED/006 $p the Centrum of clinical and experimental liver surgery
GRA    __
$a LO1503 $p Ministry of Education Youth and Sports of the Czech Republic, the National Sustainability Program I
GRA    __
$a GACR 17-16857S $p Grantová Agentura České Republiky
GRA    __
$a Post-doctoral fellowship Year 2014-2017 $p the Fondazione Umberto Veronesi
GRA    __
$a AZV MZ 15-26535A $p the Internal Grant Agency of the Ministry of Health of the Czech Republic
GRA    __
$a AZV 17-30920A $p the Internal Grant Agency of the Ministry of Health of the Czech Republic
GRA    __
$a 829675 $p the FFG BRIDGE
GRA    __
$a the Herzfelder´sche Familienstiftung $p the Herzfelder´sche Familienstiftung
GRA    __
$a GACR 15-14789S $p Grantová Agentura České Republiky
GRA    __
$a NV17-30920A $p MZ0
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...